The Right Way To
Boston Harbor Angels, like a lighthouse, helps entrepreneurs navigate and grow their start-up businesses through the treacherous waters of an increasingly competitive environment in our global economy. Boston Harbor Angels has been recognized as one of the top three elite angel groups in the U.S.
Who We Are
Boston Harbor Angels is a group of proven business leaders interested in investing a portion of our assets in high-growth, early-stage companies. Since 2004, our portfolio has included companies in information technology, life sciences, consumer products, business products, services, specialty materials, aviation and more. We believe we contribute more than just money to the companies we fund. We welcome the opportunity to work with entrepreneurs who are open to taking advice, yet have the smarts and determination to make their company successful.
Our focus is early-stage companies that are looking to raise $250K to $1.5M. We look for companies where we can fund a portion of the round and syndicate the deal with other angel groups or early-stage venture funds. The company should be close to the commercialization stage and have a clear and defensible competitive advantage. We are looking for capital-efficient businesses that can reach profitability with less than $5M of equity investment and provide at least a tenfold return on the investment within five years.
Boston Harbor Angels does not invest as a fund—each of our members makes his or her individual investment decision. Members collaborate in due diligence. We are open to any opportunities that can make a strong business case and can take the position of a lead investor if one of us has strong expertise within our group.
We are proud partners with Nutter McClennen & Fish LLP, MPR Product Development, The Bulfinch Group and Babson College.
Boston Harbor Angels was founded in February 2004 by Mic Williams. Day-to-day operations are managed by Ziad Moukheiber.
Boston Harbor Angels Facts
We have over 70 active members. Since 2004 we have made investments in over 70 start-up companies in medical devices, IT, consumer products, business products, specialty materials, Internet, aviation, etc.
Boston Harbor Angels members are early investors in SmartCells, which was bought by Merck for $500 Million in 2010, as well as in Carbonite, which had a successful IPO in August 2011.
Our members participated in all rounds of financing for SmartCells and three rounds of financing for Carbonite.
Boston Harbor Angels members are early investors in JB Therapeutics. Corbus Pharmaceuticals, formerly JB Therapeutics, successfully completed a $10.3 million private placement equity financing in June of 2014.
Corbus Pharmaceuticals, initiated trading on the Over-the-Counter Markets (OTCQB) under the ticker symbol “CRBP” in October 2014.
One of our companies received the prestigious Silvertip Luis Villalobos Award, and was recognized as one of the most impressive companies at the 2011 National Angel Capital Association Summit.